Th-17 pathway modulators (Affibody)

N/A

Report date: 2025/02/01 20:00:06

Base Information

Drug NameTh-17 pathway modulators (Affibody)
Drug Alias Nameanti-Th-17 pathway albubodies (Affibody)
ClassificationBiologics > Protein drugs > Immunoglobulin > Antibody
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsInflammationAutoimmune Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySweden
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesAffibody Medical AB
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesAffibody Medical AB
Active IndicationsN/A
Inactive IndicationsInflammationAutoimmune Diseases

Other Information

ATC CodeN/A
Related LinksN/A